|
GCC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.040770E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.757700E-02 |
| Normal-vs-Stage2 |
5.577600E-01 |
| Normal-vs-Stage3 |
2.610000E-01 |
| Normal-vs-Stage4 |
3.755000E-01 |
| Stage1-vs-Stage2 |
7.965600E-01 |
| Stage1-vs-Stage3 |
9.326400E-01 |
| Stage1-vs-Stage4 |
9.607400E-01 |
| Stage2-vs-Stage3 |
8.705200E-01 |
| Stage2-vs-Stage4 |
8.403600E-01 |
| Stage3-vs-Stage4 |
9.110400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.207800E-02 |
| Normal-vs-AfricanAmerican |
4.793400E-01 |
| Normal-vs-Asian |
7.993700E-02 |
| Caucasian-vs-AfricanAmerican |
5.331200E-01 |
| Caucasian-vs-Asian |
6.504600E-01 |
| AfricanAmerican-vs-Asian |
4.732000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.478090E-02 |
| Normal-vs-Female |
5.023200E-01 |
| Male-vs-Female |
4.739300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.233800E-02 |
| Normal-vs-Extreme_Weight |
4.601700E-03 |
| Normal-vs-Obese |
7.311200E-01 |
| Normal-vs-Extreme_Obese |
3.419500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.357400E-01 |
| Normal_Weight-vs-Obese |
3.158200E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.938200E-01 |
| Extreme_Weight-vs-Obese |
9.635200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.978800E-01 |
| Obese-vs-Extreme_Obese |
1.841190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.540000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.860200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.000700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.602200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.749200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.096000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.857800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.137970E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.829900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.847600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.710100E-02 |
| Normal-VS-Type2 PRCC |
5.137700E-02 |
| Normal-VS-KIRP CIMP |
3.413200E-01 |
| Normal-VS-Unclassified PRCC |
6.002200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.081800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.626400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.742430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.504000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.092560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.076400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.220400E-04 |
| Normal-vs-N1 |
7.285600E-01 |
| Normal-vs-N2 |
4.353600E-01 |
| N0-vs-N1 |
2.235800E-02 |
| N0-vs-N2 |
4.642400E-01 |
| N1-vs-N2 |
5.971800E-01 |
|
|
